Ev3’s Atherectomy Business On The Upswing After Troubled First Quarter
This article was originally published in The Gray Sheet
Executive Summary
Endovascular device firm ev3's formerly rocky marriage with FoxHollow is now on steadier ground with a better-than-expected recovery of its atherectomy business in the second quarter